Clinical presentation and management of patients with uncontrolled, severe hypertension: Results from a public teaching hospital

Journal of Human Hypertension

Volumn 13, Issue 4, 1999, Pages 249-255

  Preston, Richard A ^a   Baltodano, N M ^b   Cienki, J ^b   Materson, B J ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Hypertension; Hypertensive crisis; Hypertensive emergency; Hypertensive urgency; Severe hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CLONIDINE; DILTIAZEM; ENALAPRILAT; LABETALOL; METOPROLOL; NIFEDIPINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; SYSTOLIC BLOOD PRESSURE; TEACHING HOSPITAL;

EID: 0032946046     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000796     Document Type: Article

References (36)

1. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413-2444.
2. Kaplan N. Hypertensive crises. In: Kaplan N (ed). Clinical Hypertension, 7th edn. Williams and Wilkens: Baltimore, 1998, pp 265-280.
3. Preston RA, Materson BJ, Yoham MA, Anapol H. Hypertension in Haitians: pilot survey of a public teaching hospital multispecialty clinic. J Hum Hypertens 1996; 10: 743-745.
4. Shea S et al. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992; 327: 776-781.
5. Shea S et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health 1992; 82: 1607-1612.
6. Nolan DC, Linas SL. Malignant hypertension and other hypertensive crises. In: Schrier RW, Gottschalk CW (eds). Diseases of the Kidney. Little Brown and Company: Boston/Toronto/London, 1997, pp 1475-1554.
7. Mann SJ, Atlas SA. Hypertensive emergencies. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis, and Management. Raven Press, Ltd: NY, 1995, pp 1813-1836.
8. Abdelwahab W, Frishman W, Landau A. Management of hypertensive urgencies and emergencies. J Clin Pharmacol 1995; 35: 747-762.
9. Murphy C. Hypertensive emergencies. Emerg Med Clin North Am 1995; 13: 973-1007.
10. Ram CV. Immediate management of severe hypertension. Cardiol Clin 1995; 13: 579-591.
11. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13: 915-924.
12. Webster J, Petrie JC, Jeffers TA, Lovell HG. Accelerated hypertension-patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med 1993; 86: 485-493.
13. Patel R, Ansari A, Grim C. Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients. Am J Cardiol 1990; 66: 868-869.
14. Gifford RW, Jr. Management of hypertensive crises. JAMA 1991; 266: 829-835.
15. Calhoun DA, Oparil S, Treatment of hypertensive crisis. N Engl J Med 1990; 323: 1177-1183.
16. Thach A, Schultz PJ. Nonemergent hypertension. Emerg Med Clin North Am 1995; 13: 1009-1035.
17. Ferguson RK, Vlasses PH. How urgent is 'urgent' hypertension? Arch Intern Med 1989; 149: 257-258.
18. Fagan TC. Acute reduction of blood pressure in asymptomatic patients with severe hypertension. Arch Intern Med 1989; 149: 2169-2170.
19. Zeller KR, Kuhnert LV, Matthews C. Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial. Arch Intern Med 1989; 149: 2186-2189.
20. Lebby T, Paloucek F, De la Cruz F, Leiken JB. Blood pressure decrease prior to initiating pharmacological therapy in nonemergent hypertension. Am J Emerg Med 1990; 8: 27-29.
21. Lima E Jr, Zytynski LA, Camargo RF. Placebo effects in hypertensive urgency. Am J Hypertens 1997; 10: 144.
22. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996; 276: 1328-1331.
23. Dunlay MC et al. Losartan potassium as initial therapy in patients with severe hypertension. J Hum Hypertens 1995; 9: 861-867.
24. Angeli P et al. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med 1991; 151: 678-682.
25. Anderson RJ et al. Oral clonidine loading in hypertensive urgencies. JAMA 1981; 246: 848-850.
26. Bertel O et al. Nifedipine in hypertensive emergencies. Br Med J 1983; 286: 19-21.
27. Cohen IM, Katz MA. Oral clonidine loading for rapid control of hypertension. Clin Pharmacol Ther 1978; 24: 11-15.
28. Cressman MD et al. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies. Am Heart J 1984; 107: 980-985.
29. Jaker M et al. Oral nifedipine vs oral clonidine in the treatment of urgent hypertension. Arch Intern Med 1989; 149: 260-265.
30. Opie LH. Sublingual nifedipine. Lancet 1991; 338: 1203.
31. Woods DJ, Fowler S. Nifedipine for hypertensive emergencies. JAMA 1997; 227: 790-791.
32. Fenoldopam Study Group. Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Acad Emerg Med 1995; 2: 959-965.
33. Post JB, 4th, Frishman WH. Fenoldopam: A new dopamine agonist for the treatment of hypertensive urgencies and emergencies. J Clin Pharmacol 1998; 38: 2-13.
34. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. Chapter 10: 9th edn. McGraw-Hill: New York, 1996, pp 199-248.
35. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115-129 mm Hg. JAMA 1967; 202: 116-122.
36. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90-114 mm Hg. JAMA 1970; 213: 1143-1152.